nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—CYP3A5—Temsirolimus—kidney cancer	0.118	0.19	CbGbCtD
Oxcarbazepine—CYP3A4—Everolimus—kidney cancer	0.0681	0.11	CbGbCtD
Oxcarbazepine—ALB—Erlotinib—kidney cancer	0.055	0.0888	CbGbCtD
Oxcarbazepine—CYP3A4—Temsirolimus—kidney cancer	0.046	0.0743	CbGbCtD
Oxcarbazepine—CYP3A5—Erlotinib—kidney cancer	0.0442	0.0714	CbGbCtD
Oxcarbazepine—CYP3A5—Paclitaxel—kidney cancer	0.0405	0.0654	CbGbCtD
Oxcarbazepine—CYP3A5—Sorafenib—kidney cancer	0.036	0.0581	CbGbCtD
Oxcarbazepine—CYP3A5—Vincristine—kidney cancer	0.0349	0.0564	CbGbCtD
Oxcarbazepine—CYP3A5—Sunitinib—kidney cancer	0.0291	0.047	CbGbCtD
Oxcarbazepine—CYP2C19—Sorafenib—kidney cancer	0.029	0.0468	CbGbCtD
Oxcarbazepine—CYP3A4—Pazopanib—kidney cancer	0.0242	0.039	CbGbCtD
Oxcarbazepine—CYP3A4—Erlotinib—kidney cancer	0.0172	0.0278	CbGbCtD
Oxcarbazepine—CYP3A4—Paclitaxel—kidney cancer	0.0158	0.0255	CbGbCtD
Oxcarbazepine—CYP3A4—Sorafenib—kidney cancer	0.014	0.0226	CbGbCtD
Oxcarbazepine—CYP3A4—Vinblastine—kidney cancer	0.0138	0.0224	CbGbCtD
Oxcarbazepine—CYP3A4—Vincristine—kidney cancer	0.0136	0.022	CbGbCtD
Oxcarbazepine—CYP3A4—Sunitinib—kidney cancer	0.0114	0.0183	CbGbCtD
Oxcarbazepine—CYP3A4—Doxorubicin—kidney cancer	0.00851	0.0137	CbGbCtD
Oxcarbazepine—Dimetacrine—ACHE—kidney cancer	0.00108	0.148	CrCbGaD
Oxcarbazepine—Indapamide—CA9—kidney cancer	0.000884	0.122	CrCbGaD
Oxcarbazepine—Indapamide—CA2—kidney cancer	0.000795	0.109	CrCbGaD
Oxcarbazepine—Nepafenac—PTGS1—kidney cancer	0.000529	0.0728	CrCbGaD
Oxcarbazepine—Magnesium salicylate—PTGS1—kidney cancer	0.000517	0.0711	CrCbGaD
Oxcarbazepine—Piroxicam—PTGS1—kidney cancer	0.000496	0.0682	CrCbGaD
Oxcarbazepine—Salsalate—PTGS1—kidney cancer	0.000439	0.0605	CrCbGaD
Oxcarbazepine—Nepafenac—PTGS2—kidney cancer	0.000302	0.0416	CrCbGaD
Oxcarbazepine—Magnesium salicylate—PTGS2—kidney cancer	0.000295	0.0406	CrCbGaD
Oxcarbazepine—Piroxicam—PTGS2—kidney cancer	0.000283	0.039	CrCbGaD
Oxcarbazepine—Warfarin—CYP1A1—kidney cancer	0.000254	0.035	CrCbGaD
Oxcarbazepine—Salsalate—PTGS2—kidney cancer	0.000251	0.0346	CrCbGaD
Oxcarbazepine—Nortriptyline—PTGS1—kidney cancer	0.000171	0.0235	CrCbGaD
Oxcarbazepine—Epinastine—ABCB1—kidney cancer	0.000161	0.0221	CrCbGaD
Oxcarbazepine—Diazepam—PTGS1—kidney cancer	0.000129	0.0178	CrCbGaD
Oxcarbazepine—Constipation—Gemcitabine—kidney cancer	0.000113	0.00033	CcSEcCtD
Oxcarbazepine—Nausea—Erlotinib—kidney cancer	0.000113	0.00033	CcSEcCtD
Oxcarbazepine—Alopecia—Capecitabine—kidney cancer	0.000113	0.00033	CcSEcCtD
Oxcarbazepine—Dry mouth—Paclitaxel—kidney cancer	0.000113	0.00033	CcSEcCtD
Oxcarbazepine—Mood swings—Doxorubicin—kidney cancer	0.000113	0.000329	CcSEcCtD
Oxcarbazepine—Diarrhoea—Sunitinib—kidney cancer	0.000113	0.000329	CcSEcCtD
Oxcarbazepine—Ataxia—Doxorubicin—kidney cancer	0.000112	0.000327	CcSEcCtD
Oxcarbazepine—Mental disorder—Capecitabine—kidney cancer	0.000112	0.000327	CcSEcCtD
Oxcarbazepine—Asthenia—Dactinomycin—kidney cancer	0.000112	0.000327	CcSEcCtD
Oxcarbazepine—Confusional state—Paclitaxel—kidney cancer	0.000112	0.000326	CcSEcCtD
Oxcarbazepine—Malnutrition—Capecitabine—kidney cancer	0.000112	0.000325	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000111	0.000323	CcSEcCtD
Oxcarbazepine—Body temperature increased—Vincristine—kidney cancer	0.000111	0.000322	CcSEcCtD
Oxcarbazepine—Abdominal pain—Vincristine—kidney cancer	0.000111	0.000322	CcSEcCtD
Oxcarbazepine—Liver function test abnormal—Doxorubicin—kidney cancer	0.00011	0.000321	CcSEcCtD
Oxcarbazepine—Infection—Paclitaxel—kidney cancer	0.00011	0.000321	CcSEcCtD
Oxcarbazepine—Flatulence—Capecitabine—kidney cancer	0.00011	0.00032	CcSEcCtD
Oxcarbazepine—Dysgeusia—Capecitabine—kidney cancer	0.000109	0.000318	CcSEcCtD
Oxcarbazepine—Dizziness—Sunitinib—kidney cancer	0.000109	0.000318	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Gemcitabine—kidney cancer	0.000109	0.000318	CcSEcCtD
Oxcarbazepine—Shock—Paclitaxel—kidney cancer	0.000109	0.000318	CcSEcCtD
Oxcarbazepine—Vomiting—Sorafenib—kidney cancer	0.000109	0.000318	CcSEcCtD
Oxcarbazepine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000109	0.000318	CcSEcCtD
Oxcarbazepine—Abdominal pain upper—Doxorubicin—kidney cancer	0.000109	0.000318	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Paclitaxel—kidney cancer	0.000109	0.000317	CcSEcCtD
Oxcarbazepine—Hypokalaemia—Doxorubicin—kidney cancer	0.000109	0.000316	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000109	0.000316	CcSEcCtD
Oxcarbazepine—Tachycardia—Paclitaxel—kidney cancer	0.000108	0.000315	CcSEcCtD
Oxcarbazepine—Rash—Sorafenib—kidney cancer	0.000108	0.000315	CcSEcCtD
Oxcarbazepine—Dermatitis—Sorafenib—kidney cancer	0.000108	0.000315	CcSEcCtD
Oxcarbazepine—Back pain—Capecitabine—kidney cancer	0.000108	0.000314	CcSEcCtD
Oxcarbazepine—Skin disorder—Paclitaxel—kidney cancer	0.000108	0.000314	CcSEcCtD
Oxcarbazepine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000108	0.000313	CcSEcCtD
Oxcarbazepine—Headache—Sorafenib—kidney cancer	0.000108	0.000313	CcSEcCtD
Oxcarbazepine—Clobazam—ABCB1—kidney cancer	0.000108	0.0148	CrCbGaD
Oxcarbazepine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000107	0.000312	CcSEcCtD
Oxcarbazepine—Diarrhoea—Dactinomycin—kidney cancer	0.000107	0.000311	CcSEcCtD
Oxcarbazepine—Nasopharyngitis—Doxorubicin—kidney cancer	0.000107	0.000311	CcSEcCtD
Oxcarbazepine—Anorexia—Paclitaxel—kidney cancer	0.000106	0.000308	CcSEcCtD
Oxcarbazepine—Gastritis—Doxorubicin—kidney cancer	0.000106	0.000308	CcSEcCtD
Oxcarbazepine—Muscular weakness—Doxorubicin—kidney cancer	0.000105	0.000307	CcSEcCtD
Oxcarbazepine—Vision blurred—Capecitabine—kidney cancer	0.000105	0.000306	CcSEcCtD
Oxcarbazepine—Vomiting—Sunitinib—kidney cancer	0.000105	0.000306	CcSEcCtD
Oxcarbazepine—Body temperature increased—Gemcitabine—kidney cancer	0.000105	0.000305	CcSEcCtD
Oxcarbazepine—Tremor—Capecitabine—kidney cancer	0.000105	0.000304	CcSEcCtD
Oxcarbazepine—Rash—Sunitinib—kidney cancer	0.000104	0.000303	CcSEcCtD
Oxcarbazepine—Dermatitis—Sunitinib—kidney cancer	0.000104	0.000303	CcSEcCtD
Oxcarbazepine—Hypotension—Paclitaxel—kidney cancer	0.000104	0.000302	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Capecitabine—kidney cancer	0.000104	0.000301	CcSEcCtD
Oxcarbazepine—Headache—Sunitinib—kidney cancer	0.000104	0.000301	CcSEcCtD
Oxcarbazepine—Asthma—Doxorubicin—kidney cancer	0.000103	0.000301	CcSEcCtD
Oxcarbazepine—Dysphagia—Doxorubicin—kidney cancer	0.000103	0.000301	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Vincristine—kidney cancer	0.000103	0.0003	CcSEcCtD
Oxcarbazepine—Eosinophilia—Doxorubicin—kidney cancer	0.000102	0.000298	CcSEcCtD
Oxcarbazepine—Nausea—Sorafenib—kidney cancer	0.000102	0.000297	CcSEcCtD
Oxcarbazepine—Pancreatitis—Doxorubicin—kidney cancer	0.000101	0.000295	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000101	0.000294	CcSEcCtD
Oxcarbazepine—Carbamazepine—ABCB1—kidney cancer	0.000101	0.0139	CrCbGaD
Oxcarbazepine—Malaise—Capecitabine—kidney cancer	0.000101	0.000293	CcSEcCtD
Oxcarbazepine—Insomnia—Paclitaxel—kidney cancer	0.0001	0.000292	CcSEcCtD
Oxcarbazepine—Vertigo—Capecitabine—kidney cancer	0.0001	0.000292	CcSEcCtD
Oxcarbazepine—Asthenia—Vincristine—kidney cancer	0.0001	0.000292	CcSEcCtD
Oxcarbazepine—Syncope—Capecitabine—kidney cancer	0.0001	0.000291	CcSEcCtD
Oxcarbazepine—Leukopenia—Capecitabine—kidney cancer	9.99e-05	0.000291	CcSEcCtD
Oxcarbazepine—Vomiting—Dactinomycin—kidney cancer	9.95e-05	0.000289	CcSEcCtD
Oxcarbazepine—Bronchitis—Doxorubicin—kidney cancer	9.93e-05	0.000289	CcSEcCtD
Oxcarbazepine—Dyspnoea—Paclitaxel—kidney cancer	9.9e-05	0.000288	CcSEcCtD
Oxcarbazepine—Somnolence—Paclitaxel—kidney cancer	9.87e-05	0.000287	CcSEcCtD
Oxcarbazepine—Palpitations—Capecitabine—kidney cancer	9.87e-05	0.000287	CcSEcCtD
Oxcarbazepine—Rash—Dactinomycin—kidney cancer	9.87e-05	0.000287	CcSEcCtD
Oxcarbazepine—Nausea—Sunitinib—kidney cancer	9.82e-05	0.000286	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Capecitabine—kidney cancer	9.81e-05	0.000286	CcSEcCtD
Oxcarbazepine—Pancytopenia—Doxorubicin—kidney cancer	9.81e-05	0.000285	CcSEcCtD
Oxcarbazepine—Dyspepsia—Paclitaxel—kidney cancer	9.77e-05	0.000284	CcSEcCtD
Oxcarbazepine—Cough—Capecitabine—kidney cancer	9.74e-05	0.000283	CcSEcCtD
Oxcarbazepine—Dysuria—Doxorubicin—kidney cancer	9.66e-05	0.000281	CcSEcCtD
Oxcarbazepine—Neutropenia—Doxorubicin—kidney cancer	9.66e-05	0.000281	CcSEcCtD
Oxcarbazepine—Decreased appetite—Paclitaxel—kidney cancer	9.65e-05	0.000281	CcSEcCtD
Oxcarbazepine—Hypertension—Capecitabine—kidney cancer	9.64e-05	0.00028	CcSEcCtD
Oxcarbazepine—Upper respiratory tract infection—Doxorubicin—kidney cancer	9.6e-05	0.000279	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Paclitaxel—kidney cancer	9.59e-05	0.000279	CcSEcCtD
Oxcarbazepine—Fatigue—Paclitaxel—kidney cancer	9.57e-05	0.000279	CcSEcCtD
Oxcarbazepine—Diarrhoea—Vincristine—kidney cancer	9.57e-05	0.000278	CcSEcCtD
Oxcarbazepine—Pollakiuria—Doxorubicin—kidney cancer	9.54e-05	0.000278	CcSEcCtD
Oxcarbazepine—Asthenia—Gemcitabine—kidney cancer	9.52e-05	0.000277	CcSEcCtD
Oxcarbazepine—Arthralgia—Capecitabine—kidney cancer	9.51e-05	0.000277	CcSEcCtD
Oxcarbazepine—Chest pain—Capecitabine—kidney cancer	9.51e-05	0.000277	CcSEcCtD
Oxcarbazepine—Myalgia—Capecitabine—kidney cancer	9.51e-05	0.000277	CcSEcCtD
Oxcarbazepine—Pain—Paclitaxel—kidney cancer	9.5e-05	0.000276	CcSEcCtD
Oxcarbazepine—Constipation—Paclitaxel—kidney cancer	9.5e-05	0.000276	CcSEcCtD
Oxcarbazepine—Anxiety—Capecitabine—kidney cancer	9.47e-05	0.000276	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	9.44e-05	0.000275	CcSEcCtD
Oxcarbazepine—Photosensitivity reaction—Doxorubicin—kidney cancer	9.43e-05	0.000274	CcSEcCtD
Oxcarbazepine—Weight increased—Doxorubicin—kidney cancer	9.4e-05	0.000273	CcSEcCtD
Oxcarbazepine—Discomfort—Capecitabine—kidney cancer	9.39e-05	0.000273	CcSEcCtD
Oxcarbazepine—Pruritus—Gemcitabine—kidney cancer	9.38e-05	0.000273	CcSEcCtD
Oxcarbazepine—Weight decreased—Doxorubicin—kidney cancer	9.35e-05	0.000272	CcSEcCtD
Oxcarbazepine—Hyperglycaemia—Doxorubicin—kidney cancer	9.32e-05	0.000271	CcSEcCtD
Oxcarbazepine—Dry mouth—Capecitabine—kidney cancer	9.3e-05	0.00027	CcSEcCtD
Oxcarbazepine—Nausea—Dactinomycin—kidney cancer	9.3e-05	0.00027	CcSEcCtD
Oxcarbazepine—Pneumonia—Doxorubicin—kidney cancer	9.26e-05	0.00027	CcSEcCtD
Oxcarbazepine—Dizziness—Vincristine—kidney cancer	9.25e-05	0.000269	CcSEcCtD
Oxcarbazepine—Infestation NOS—Doxorubicin—kidney cancer	9.21e-05	0.000268	CcSEcCtD
Oxcarbazepine—Infestation—Doxorubicin—kidney cancer	9.21e-05	0.000268	CcSEcCtD
Oxcarbazepine—Confusional state—Capecitabine—kidney cancer	9.19e-05	0.000267	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Paclitaxel—kidney cancer	9.15e-05	0.000266	CcSEcCtD
Oxcarbazepine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	9.13e-05	0.000266	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Paclitaxel—kidney cancer	9.08e-05	0.000264	CcSEcCtD
Oxcarbazepine—Diarrhoea—Gemcitabine—kidney cancer	9.07e-05	0.000264	CcSEcCtD
Oxcarbazepine—Renal failure—Doxorubicin—kidney cancer	9.05e-05	0.000263	CcSEcCtD
Oxcarbazepine—Infection—Capecitabine—kidney cancer	9.05e-05	0.000263	CcSEcCtD
Oxcarbazepine—Stomatitis—Doxorubicin—kidney cancer	8.98e-05	0.000261	CcSEcCtD
Oxcarbazepine—Shock—Capecitabine—kidney cancer	8.97e-05	0.000261	CcSEcCtD
Oxcarbazepine—Urinary tract infection—Doxorubicin—kidney cancer	8.95e-05	0.00026	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Capecitabine—kidney cancer	8.94e-05	0.00026	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Capecitabine—kidney cancer	8.92e-05	0.00026	CcSEcCtD
Oxcarbazepine—Tachycardia—Capecitabine—kidney cancer	8.89e-05	0.000259	CcSEcCtD
Oxcarbazepine—Vomiting—Vincristine—kidney cancer	8.89e-05	0.000259	CcSEcCtD
Oxcarbazepine—Skin disorder—Capecitabine—kidney cancer	8.85e-05	0.000258	CcSEcCtD
Oxcarbazepine—Urticaria—Paclitaxel—kidney cancer	8.82e-05	0.000257	CcSEcCtD
Oxcarbazepine—Rash—Vincristine—kidney cancer	8.82e-05	0.000256	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Capecitabine—kidney cancer	8.81e-05	0.000256	CcSEcCtD
Oxcarbazepine—Dermatitis—Vincristine—kidney cancer	8.81e-05	0.000256	CcSEcCtD
Oxcarbazepine—Haematuria—Doxorubicin—kidney cancer	8.78e-05	0.000255	CcSEcCtD
Oxcarbazepine—Body temperature increased—Paclitaxel—kidney cancer	8.78e-05	0.000255	CcSEcCtD
Oxcarbazepine—Abdominal pain—Paclitaxel—kidney cancer	8.78e-05	0.000255	CcSEcCtD
Oxcarbazepine—Headache—Vincristine—kidney cancer	8.76e-05	0.000255	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Doxorubicin—kidney cancer	8.71e-05	0.000253	CcSEcCtD
Oxcarbazepine—Epistaxis—Doxorubicin—kidney cancer	8.69e-05	0.000253	CcSEcCtD
Oxcarbazepine—Anorexia—Capecitabine—kidney cancer	8.69e-05	0.000253	CcSEcCtD
Oxcarbazepine—Sinusitis—Doxorubicin—kidney cancer	8.64e-05	0.000251	CcSEcCtD
Oxcarbazepine—Agranulocytosis—Doxorubicin—kidney cancer	8.6e-05	0.00025	CcSEcCtD
Oxcarbazepine—Hypotension—Capecitabine—kidney cancer	8.52e-05	0.000248	CcSEcCtD
Oxcarbazepine—Vomiting—Gemcitabine—kidney cancer	8.43e-05	0.000245	CcSEcCtD
Oxcarbazepine—Bradycardia—Doxorubicin—kidney cancer	8.42e-05	0.000245	CcSEcCtD
Oxcarbazepine—Rash—Gemcitabine—kidney cancer	8.36e-05	0.000243	CcSEcCtD
Oxcarbazepine—Dermatitis—Gemcitabine—kidney cancer	8.36e-05	0.000243	CcSEcCtD
Oxcarbazepine—Headache—Gemcitabine—kidney cancer	8.31e-05	0.000242	CcSEcCtD
Oxcarbazepine—Nausea—Vincristine—kidney cancer	8.3e-05	0.000242	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.3e-05	0.000242	CcSEcCtD
Oxcarbazepine—Rhinitis—Doxorubicin—kidney cancer	8.29e-05	0.000241	CcSEcCtD
Oxcarbazepine—Hepatitis—Doxorubicin—kidney cancer	8.27e-05	0.000241	CcSEcCtD
Oxcarbazepine—Insomnia—Capecitabine—kidney cancer	8.24e-05	0.00024	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Doxorubicin—kidney cancer	8.23e-05	0.000239	CcSEcCtD
Oxcarbazepine—Pharyngitis—Doxorubicin—kidney cancer	8.21e-05	0.000239	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Paclitaxel—kidney cancer	8.18e-05	0.000238	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Doxorubicin—kidney cancer	8.15e-05	0.000237	CcSEcCtD
Oxcarbazepine—Dyspnoea—Capecitabine—kidney cancer	8.12e-05	0.000236	CcSEcCtD
Oxcarbazepine—Dyspepsia—Capecitabine—kidney cancer	8.02e-05	0.000233	CcSEcCtD
Oxcarbazepine—Visual impairment—Doxorubicin—kidney cancer	7.97e-05	0.000232	CcSEcCtD
Oxcarbazepine—Asthenia—Paclitaxel—kidney cancer	7.97e-05	0.000232	CcSEcCtD
Oxcarbazepine—Decreased appetite—Capecitabine—kidney cancer	7.92e-05	0.00023	CcSEcCtD
Oxcarbazepine—Nausea—Gemcitabine—kidney cancer	7.88e-05	0.000229	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Capecitabine—kidney cancer	7.87e-05	0.000229	CcSEcCtD
Oxcarbazepine—Fatigue—Capecitabine—kidney cancer	7.86e-05	0.000229	CcSEcCtD
Oxcarbazepine—Pruritus—Paclitaxel—kidney cancer	7.86e-05	0.000229	CcSEcCtD
Oxcarbazepine—Trimipramine—ABCB1—kidney cancer	7.82e-05	0.0108	CrCbGaD
Oxcarbazepine—Erythema multiforme—Doxorubicin—kidney cancer	7.82e-05	0.000227	CcSEcCtD
Oxcarbazepine—Pain—Capecitabine—kidney cancer	7.79e-05	0.000227	CcSEcCtD
Oxcarbazepine—Constipation—Capecitabine—kidney cancer	7.79e-05	0.000227	CcSEcCtD
Oxcarbazepine—Eye disorder—Doxorubicin—kidney cancer	7.73e-05	0.000225	CcSEcCtD
Oxcarbazepine—Tinnitus—Doxorubicin—kidney cancer	7.71e-05	0.000224	CcSEcCtD
Oxcarbazepine—Flushing—Doxorubicin—kidney cancer	7.67e-05	0.000223	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Doxorubicin—kidney cancer	7.67e-05	0.000223	CcSEcCtD
Oxcarbazepine—Diarrhoea—Paclitaxel—kidney cancer	7.6e-05	0.000221	CcSEcCtD
Oxcarbazepine—Promethazine—ABCB1—kidney cancer	7.53e-05	0.0104	CrCbGaD
Oxcarbazepine—Feeling abnormal—Capecitabine—kidney cancer	7.51e-05	0.000218	CcSEcCtD
Oxcarbazepine—Angiopathy—Doxorubicin—kidney cancer	7.5e-05	0.000218	CcSEcCtD
Oxcarbazepine—Immune system disorder—Doxorubicin—kidney cancer	7.47e-05	0.000217	CcSEcCtD
Oxcarbazepine—Doxepin—ABCB1—kidney cancer	7.46e-05	0.0103	CrCbGaD
Oxcarbazepine—Gastrointestinal pain—Capecitabine—kidney cancer	7.45e-05	0.000217	CcSEcCtD
Oxcarbazepine—Chills—Doxorubicin—kidney cancer	7.42e-05	0.000216	CcSEcCtD
Oxcarbazepine—Arrhythmia—Doxorubicin—kidney cancer	7.39e-05	0.000215	CcSEcCtD
Oxcarbazepine—Dizziness—Paclitaxel—kidney cancer	7.34e-05	0.000214	CcSEcCtD
Oxcarbazepine—Alopecia—Doxorubicin—kidney cancer	7.31e-05	0.000213	CcSEcCtD
Oxcarbazepine—Mental disorder—Doxorubicin—kidney cancer	7.24e-05	0.000211	CcSEcCtD
Oxcarbazepine—Urticaria—Capecitabine—kidney cancer	7.24e-05	0.000211	CcSEcCtD
Oxcarbazepine—Body temperature increased—Capecitabine—kidney cancer	7.2e-05	0.00021	CcSEcCtD
Oxcarbazepine—Abdominal pain—Capecitabine—kidney cancer	7.2e-05	0.00021	CcSEcCtD
Oxcarbazepine—Malnutrition—Doxorubicin—kidney cancer	7.2e-05	0.000209	CcSEcCtD
Oxcarbazepine—Flatulence—Doxorubicin—kidney cancer	7.09e-05	0.000206	CcSEcCtD
Oxcarbazepine—Tension—Doxorubicin—kidney cancer	7.06e-05	0.000205	CcSEcCtD
Oxcarbazepine—Vomiting—Paclitaxel—kidney cancer	7.06e-05	0.000205	CcSEcCtD
Oxcarbazepine—Dysgeusia—Doxorubicin—kidney cancer	7.05e-05	0.000205	CcSEcCtD
Oxcarbazepine—Rash—Paclitaxel—kidney cancer	7e-05	0.000204	CcSEcCtD
Oxcarbazepine—Dermatitis—Paclitaxel—kidney cancer	7e-05	0.000204	CcSEcCtD
Oxcarbazepine—Nervousness—Doxorubicin—kidney cancer	6.99e-05	0.000203	CcSEcCtD
Oxcarbazepine—Back pain—Doxorubicin—kidney cancer	6.96e-05	0.000203	CcSEcCtD
Oxcarbazepine—Headache—Paclitaxel—kidney cancer	6.96e-05	0.000202	CcSEcCtD
Oxcarbazepine—Desipramine—ABCB1—kidney cancer	6.84e-05	0.00941	CrCbGaD
Oxcarbazepine—Vision blurred—Doxorubicin—kidney cancer	6.78e-05	0.000197	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Capecitabine—kidney cancer	6.71e-05	0.000195	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Doxorubicin—kidney cancer	6.68e-05	0.000194	CcSEcCtD
Oxcarbazepine—Agitation—Doxorubicin—kidney cancer	6.61e-05	0.000192	CcSEcCtD
Oxcarbazepine—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	6.61e-05	0.00222	CbGpPWpGaD
Oxcarbazepine—Nausea—Paclitaxel—kidney cancer	6.6e-05	0.000192	CcSEcCtD
Oxcarbazepine—Asthenia—Capecitabine—kidney cancer	6.54e-05	0.00019	CcSEcCtD
Oxcarbazepine—ALB—Hemostasis—L1CAM—kidney cancer	6.53e-05	0.0022	CbGpPWpGaD
Oxcarbazepine—Malaise—Doxorubicin—kidney cancer	6.49e-05	0.000189	CcSEcCtD
Oxcarbazepine—Vertigo—Doxorubicin—kidney cancer	6.47e-05	0.000188	CcSEcCtD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTT1—kidney cancer	6.46e-05	0.00217	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—ITPR2—kidney cancer	6.46e-05	0.00217	CbGpPWpGaD
Oxcarbazepine—Syncope—Doxorubicin—kidney cancer	6.45e-05	0.000188	CcSEcCtD
Oxcarbazepine—Pruritus—Capecitabine—kidney cancer	6.45e-05	0.000188	CcSEcCtD
Oxcarbazepine—Leukopenia—Doxorubicin—kidney cancer	6.44e-05	0.000187	CcSEcCtD
Oxcarbazepine—Palpitations—Doxorubicin—kidney cancer	6.36e-05	0.000185	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Doxorubicin—kidney cancer	6.33e-05	0.000184	CcSEcCtD
Oxcarbazepine—Cough—Doxorubicin—kidney cancer	6.28e-05	0.000183	CcSEcCtD
Oxcarbazepine—Diazepam—ABCB1—kidney cancer	6.28e-05	0.00864	CrCbGaD
Oxcarbazepine—Convulsion—Doxorubicin—kidney cancer	6.24e-05	0.000181	CcSEcCtD
Oxcarbazepine—Diarrhoea—Capecitabine—kidney cancer	6.24e-05	0.000181	CcSEcCtD
Oxcarbazepine—CYP2C19—Arachidonic acid metabolism—PTGS2—kidney cancer	6.23e-05	0.00209	CbGpPWpGaD
Oxcarbazepine—Hypertension—Doxorubicin—kidney cancer	6.21e-05	0.000181	CcSEcCtD
Oxcarbazepine—Arthralgia—Doxorubicin—kidney cancer	6.13e-05	0.000178	CcSEcCtD
Oxcarbazepine—Myalgia—Doxorubicin—kidney cancer	6.13e-05	0.000178	CcSEcCtD
Oxcarbazepine—Chest pain—Doxorubicin—kidney cancer	6.13e-05	0.000178	CcSEcCtD
Oxcarbazepine—Anxiety—Doxorubicin—kidney cancer	6.11e-05	0.000178	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.09e-05	0.000177	CcSEcCtD
Oxcarbazepine—Discomfort—Doxorubicin—kidney cancer	6.05e-05	0.000176	CcSEcCtD
Oxcarbazepine—CYP2C19—Biological oxidations—PTGS1—kidney cancer	6.05e-05	0.00203	CbGpPWpGaD
Oxcarbazepine—Dizziness—Capecitabine—kidney cancer	6.03e-05	0.000175	CcSEcCtD
Oxcarbazepine—Dry mouth—Doxorubicin—kidney cancer	5.99e-05	0.000174	CcSEcCtD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	5.95e-05	0.002	CbGpPWpGaD
Oxcarbazepine—Confusional state—Doxorubicin—kidney cancer	5.92e-05	0.000172	CcSEcCtD
Oxcarbazepine—SCN5A—Axon guidance—KDR—kidney cancer	5.9e-05	0.00198	CbGpPWpGaD
Oxcarbazepine—Anaphylactic shock—Doxorubicin—kidney cancer	5.87e-05	0.000171	CcSEcCtD
Oxcarbazepine—Infection—Doxorubicin—kidney cancer	5.84e-05	0.00017	CcSEcCtD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—VEGFA—kidney cancer	5.83e-05	0.00196	CbGpPWpGaD
Oxcarbazepine—Imipramine—ABCB1—kidney cancer	5.8e-05	0.00798	CrCbGaD
Oxcarbazepine—Vomiting—Capecitabine—kidney cancer	5.79e-05	0.000169	CcSEcCtD
Oxcarbazepine—CYP3A5—Biological oxidations—GSTP1—kidney cancer	5.79e-05	0.00195	CbGpPWpGaD
Oxcarbazepine—Shock—Doxorubicin—kidney cancer	5.78e-05	0.000168	CcSEcCtD
Oxcarbazepine—SCN5A—Axon guidance—MET—kidney cancer	5.77e-05	0.00194	CbGpPWpGaD
Oxcarbazepine—Amitriptyline—ABCB1—kidney cancer	5.77e-05	0.00793	CrCbGaD
Oxcarbazepine—Nervous system disorder—Doxorubicin—kidney cancer	5.76e-05	0.000168	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Doxorubicin—kidney cancer	5.75e-05	0.000167	CcSEcCtD
Oxcarbazepine—Rash—Capecitabine—kidney cancer	5.75e-05	0.000167	CcSEcCtD
Oxcarbazepine—Dermatitis—Capecitabine—kidney cancer	5.74e-05	0.000167	CcSEcCtD
Oxcarbazepine—Tachycardia—Doxorubicin—kidney cancer	5.73e-05	0.000167	CcSEcCtD
Oxcarbazepine—ALB—Folate Metabolism—RELA—kidney cancer	5.72e-05	0.00192	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—GSTP1—kidney cancer	5.71e-05	0.00192	CbGpPWpGaD
Oxcarbazepine—Headache—Capecitabine—kidney cancer	5.71e-05	0.000166	CcSEcCtD
Oxcarbazepine—Skin disorder—Doxorubicin—kidney cancer	5.71e-05	0.000166	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Doxorubicin—kidney cancer	5.68e-05	0.000165	CcSEcCtD
Oxcarbazepine—Anorexia—Doxorubicin—kidney cancer	5.6e-05	0.000163	CcSEcCtD
Oxcarbazepine—Hypotension—Doxorubicin—kidney cancer	5.49e-05	0.00016	CcSEcCtD
Oxcarbazepine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.47e-05	0.00184	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	5.45e-05	0.00183	CbGpPWpGaD
Oxcarbazepine—Nausea—Capecitabine—kidney cancer	5.41e-05	0.000157	CcSEcCtD
Oxcarbazepine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	5.37e-05	0.00181	CbGpPWpGaD
Oxcarbazepine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.35e-05	0.000156	CcSEcCtD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	5.34e-05	0.00179	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—GSTM1—kidney cancer	5.32e-05	0.00179	CbGpPWpGaD
Oxcarbazepine—Insomnia—Doxorubicin—kidney cancer	5.31e-05	0.000155	CcSEcCtD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—GSTM1—kidney cancer	5.25e-05	0.00176	CbGpPWpGaD
Oxcarbazepine—Dyspnoea—Doxorubicin—kidney cancer	5.24e-05	0.000152	CcSEcCtD
Oxcarbazepine—Somnolence—Doxorubicin—kidney cancer	5.22e-05	0.000152	CcSEcCtD
Oxcarbazepine—Dyspepsia—Doxorubicin—kidney cancer	5.17e-05	0.00015	CcSEcCtD
Oxcarbazepine—ALB—Folate Metabolism—IL2—kidney cancer	5.15e-05	0.00173	CbGpPWpGaD
Oxcarbazepine—Decreased appetite—Doxorubicin—kidney cancer	5.11e-05	0.000149	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.07e-05	0.000148	CcSEcCtD
Oxcarbazepine—Fatigue—Doxorubicin—kidney cancer	5.06e-05	0.000147	CcSEcCtD
Oxcarbazepine—CYP3A5—Biological oxidations—CYP1A1—kidney cancer	5.04e-05	0.0017	CbGpPWpGaD
Oxcarbazepine—Constipation—Doxorubicin—kidney cancer	5.02e-05	0.000146	CcSEcCtD
Oxcarbazepine—Pain—Doxorubicin—kidney cancer	5.02e-05	0.000146	CcSEcCtD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—CYP1A1—kidney cancer	4.97e-05	0.00167	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—ANXA2—kidney cancer	4.95e-05	0.00166	CbGpPWpGaD
Oxcarbazepine—Feeling abnormal—Doxorubicin—kidney cancer	4.84e-05	0.000141	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Doxorubicin—kidney cancer	4.8e-05	0.00014	CcSEcCtD
Oxcarbazepine—Urticaria—Doxorubicin—kidney cancer	4.67e-05	0.000136	CcSEcCtD
Oxcarbazepine—Abdominal pain—Doxorubicin—kidney cancer	4.64e-05	0.000135	CcSEcCtD
Oxcarbazepine—Body temperature increased—Doxorubicin—kidney cancer	4.64e-05	0.000135	CcSEcCtD
Oxcarbazepine—ALB—Selenium Micronutrient Network—RELA—kidney cancer	4.54e-05	0.00153	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTP1—kidney cancer	4.48e-05	0.0015	CbGpPWpGaD
Oxcarbazepine—ALB—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	4.45e-05	0.0015	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ACY1—kidney cancer	4.44e-05	0.00149	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—PTGS2—kidney cancer	4.42e-05	0.00148	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	4.42e-05	0.00148	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	4.41e-05	0.00148	CbGpPWpGaD
Oxcarbazepine—Hypersensitivity—Doxorubicin—kidney cancer	4.33e-05	0.000126	CcSEcCtD
Oxcarbazepine—ALB—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	4.3e-05	0.00144	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—ATP7B—kidney cancer	4.29e-05	0.00144	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—SLC5A3—kidney cancer	4.29e-05	0.00144	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—ANXA2—kidney cancer	4.29e-05	0.00144	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—RAF1—kidney cancer	4.27e-05	0.00143	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—ERBB2—kidney cancer	4.22e-05	0.00142	CbGpPWpGaD
Oxcarbazepine—Asthenia—Doxorubicin—kidney cancer	4.21e-05	0.000123	CcSEcCtD
Oxcarbazepine—SCN5A—Developmental Biology—KDR—kidney cancer	4.21e-05	0.00142	CbGpPWpGaD
Oxcarbazepine—Pruritus—Doxorubicin—kidney cancer	4.16e-05	0.000121	CcSEcCtD
Oxcarbazepine—SCN5A—Developmental Biology—MET—kidney cancer	4.12e-05	0.00138	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTM1—kidney cancer	4.11e-05	0.00138	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—KCNMA1—kidney cancer	4.1e-05	0.00138	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	4.06e-05	0.00136	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	4.06e-05	0.00136	CbGpPWpGaD
Oxcarbazepine—Diarrhoea—Doxorubicin—kidney cancer	4.02e-05	0.000117	CcSEcCtD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—IGF2—kidney cancer	3.97e-05	0.00133	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	3.9e-05	0.00131	CbGpPWpGaD
Oxcarbazepine—Dizziness—Doxorubicin—kidney cancer	3.88e-05	0.000113	CcSEcCtD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTT1—kidney cancer	3.88e-05	0.00131	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	3.85e-05	0.00129	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ACY1—kidney cancer	3.82e-05	0.00128	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PDHB—kidney cancer	3.77e-05	0.00127	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—POMC—kidney cancer	3.76e-05	0.00126	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—VEGFA—kidney cancer	3.75e-05	0.00126	CbGpPWpGaD
Oxcarbazepine—Vomiting—Doxorubicin—kidney cancer	3.73e-05	0.000109	CcSEcCtD
Oxcarbazepine—Rash—Doxorubicin—kidney cancer	3.7e-05	0.000108	CcSEcCtD
Oxcarbazepine—Dermatitis—Doxorubicin—kidney cancer	3.7e-05	0.000108	CcSEcCtD
Oxcarbazepine—Headache—Doxorubicin—kidney cancer	3.68e-05	0.000107	CcSEcCtD
Oxcarbazepine—CYP3A4—Biological oxidations—PTGS1—kidney cancer	3.64e-05	0.00122	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—GRB7—kidney cancer	3.58e-05	0.0012	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	3.58e-05	0.0012	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CCBL1—kidney cancer	3.55e-05	0.00119	CbGpPWpGaD
Oxcarbazepine—Nausea—Doxorubicin—kidney cancer	3.49e-05	0.000102	CcSEcCtD
Oxcarbazepine—CYP2C19—Metabolism—ACY1—kidney cancer	3.43e-05	0.00115	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—ITPR2—kidney cancer	3.33e-05	0.00112	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—TP53—kidney cancer	3.31e-05	0.00111	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.29e-05	0.00111	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.26e-05	0.0011	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—VEGFA—kidney cancer	3.25e-05	0.00109	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PDHB—kidney cancer	3.25e-05	0.00109	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PPAT—kidney cancer	3.08e-05	0.00103	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GLIPR1—kidney cancer	3.08e-05	0.00103	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—MAPK3—kidney cancer	3.08e-05	0.00103	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CCBL1—kidney cancer	3.05e-05	0.00103	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—RAF1—kidney cancer	3.04e-05	0.00102	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—RELA—kidney cancer	3.03e-05	0.00102	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—ERBB2—kidney cancer	3.01e-05	0.00101	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—MAPK1—kidney cancer	2.93e-05	0.000983	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.93e-05	0.000983	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PDHB—kidney cancer	2.92e-05	0.00098	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—POMC—kidney cancer	2.91e-05	0.000977	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—FH—kidney cancer	2.86e-05	0.000961	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—APRT—kidney cancer	2.86e-05	0.000961	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—KRAS—kidney cancer	2.76e-05	0.000929	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.76e-05	0.000928	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CCBL1—kidney cancer	2.74e-05	0.000922	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.69e-05	0.000905	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GPC3—kidney cancer	2.69e-05	0.000903	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.65e-05	0.000892	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PPAT—kidney cancer	2.65e-05	0.00089	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GLIPR1—kidney cancer	2.65e-05	0.00089	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—CTNNB1—kidney cancer	2.64e-05	0.000886	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.62e-05	0.000879	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CA2—kidney cancer	2.62e-05	0.000879	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.59e-05	0.00087	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ALAD—kidney cancer	2.55e-05	0.000856	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ST3GAL2—kidney cancer	2.49e-05	0.000836	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.48e-05	0.000834	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.47e-05	0.000831	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—FH—kidney cancer	2.46e-05	0.000828	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—APRT—kidney cancer	2.46e-05	0.000828	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IFNA1—kidney cancer	2.44e-05	0.000821	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.44e-05	0.00082	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ALDH1A1—kidney cancer	2.43e-05	0.000817	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.41e-05	0.000809	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GLIPR1—kidney cancer	2.38e-05	0.000799	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PPAT—kidney cancer	2.38e-05	0.000799	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.35e-05	0.000789	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.35e-05	0.000788	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PGK1—kidney cancer	2.33e-05	0.000783	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SLC5A3—kidney cancer	2.33e-05	0.000783	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.32e-05	0.000781	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—VEGFA—kidney cancer	2.32e-05	0.00078	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GPC3—kidney cancer	2.32e-05	0.000778	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.31e-05	0.000777	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—LDHB—kidney cancer	2.29e-05	0.000768	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IFNA2—kidney cancer	2.27e-05	0.000764	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.26e-05	0.00076	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CA2—kidney cancer	2.25e-05	0.000757	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—APRT—kidney cancer	2.21e-05	0.000743	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—FH—kidney cancer	2.21e-05	0.000743	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ALAD—kidney cancer	2.19e-05	0.000738	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—MAPK3—kidney cancer	2.19e-05	0.000738	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	2.19e-05	0.000734	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.18e-05	0.000734	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.16e-05	0.000726	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ST3GAL2—kidney cancer	2.14e-05	0.00072	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ALDH1A1—kidney cancer	2.09e-05	0.000704	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—MAPK1—kidney cancer	2.09e-05	0.000702	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GPC3—kidney cancer	2.08e-05	0.000698	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ACY1—kidney cancer	2.06e-05	0.000693	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IGF2—kidney cancer	2.05e-05	0.000688	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CA2—kidney cancer	2.02e-05	0.000679	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PGK1—kidney cancer	2.01e-05	0.000675	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SLC5A3—kidney cancer	2.01e-05	0.000675	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CA9—kidney cancer	1.98e-05	0.000666	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—KRAS—kidney cancer	1.97e-05	0.000663	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALAD—kidney cancer	1.97e-05	0.000662	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—LDHB—kidney cancer	1.97e-05	0.000662	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	1.96e-05	0.000659	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.92e-05	0.000646	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.88e-05	0.000632	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PGK1—kidney cancer	1.8e-05	0.000606	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.8e-05	0.000606	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—LDHB—kidney cancer	1.77e-05	0.000594	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PDHB—kidney cancer	1.75e-05	0.000589	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—POMC—kidney cancer	1.75e-05	0.000588	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.72e-05	0.000579	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CA9—kidney cancer	1.71e-05	0.000574	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CRABP1—kidney cancer	1.69e-05	0.000566	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.67e-05	0.000561	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	1.67e-05	0.00056	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CCBL1—kidney cancer	1.65e-05	0.000554	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.58e-05	0.000529	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ITPR2—kidney cancer	1.57e-05	0.000527	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CA9—kidney cancer	1.53e-05	0.000515	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.5e-05	0.000504	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.5e-05	0.000503	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CRABP1—kidney cancer	1.45e-05	0.000488	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.43e-05	0.000481	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PPAT—kidney cancer	1.43e-05	0.000481	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTT1—kidney cancer	1.43e-05	0.00048	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ACHE—kidney cancer	1.43e-05	0.00048	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SCARB1—kidney cancer	1.35e-05	0.000454	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ITPR2—kidney cancer	1.35e-05	0.000453	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PTGS1—kidney cancer	1.34e-05	0.00045	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—APRT—kidney cancer	1.33e-05	0.000447	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—FH—kidney cancer	1.33e-05	0.000447	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PSMD7—kidney cancer	1.31e-05	0.000441	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CRABP1—kidney cancer	1.3e-05	0.000438	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.3e-05	0.000437	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GPC3—kidney cancer	1.25e-05	0.00042	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—BCHE—kidney cancer	1.24e-05	0.000418	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.24e-05	0.000418	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTT1—kidney cancer	1.23e-05	0.000414	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ACHE—kidney cancer	1.23e-05	0.000414	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.23e-05	0.000413	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CA2—kidney cancer	1.22e-05	0.000409	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ITPR2—kidney cancer	1.21e-05	0.000407	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.19e-05	0.000399	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALAD—kidney cancer	1.18e-05	0.000398	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SCARB1—kidney cancer	1.16e-05	0.000391	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.16e-05	0.000389	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PTGS1—kidney cancer	1.15e-05	0.000387	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PSMD7—kidney cancer	1.13e-05	0.00038	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.13e-05	0.00038	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—RAF1—kidney cancer	1.13e-05	0.000379	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.12e-05	0.000375	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ACHE—kidney cancer	1.1e-05	0.000371	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTT1—kidney cancer	1.1e-05	0.000371	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.08e-05	0.000364	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PGK1—kidney cancer	1.08e-05	0.000364	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—BCHE—kidney cancer	1.07e-05	0.00036	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—LDHB—kidney cancer	1.06e-05	0.000357	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SLC5A5—kidney cancer	1.06e-05	0.000356	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SCARB1—kidney cancer	1.05e-05	0.000351	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PTGS1—kidney cancer	1.03e-05	0.000348	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SLC2A1—kidney cancer	1.02e-05	0.000344	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PSMD7—kidney cancer	1.01e-05	0.000341	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IL2—kidney cancer	1.01e-05	0.000339	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.92e-06	0.000333	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTP1—kidney cancer	9.9e-06	0.000333	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	9.75e-06	0.000328	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—BCHE—kidney cancer	9.62e-06	0.000323	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SLC5A5—kidney cancer	9.5e-06	0.000319	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ABCB1—kidney cancer	9.37e-06	0.000315	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CA9—kidney cancer	9.21e-06	0.00031	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SLC2A1—kidney cancer	9.18e-06	0.000308	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTM1—kidney cancer	9.1e-06	0.000306	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.91e-06	0.000299	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.65e-06	0.000291	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP1A1—kidney cancer	8.63e-06	0.00029	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—VEGFA—kidney cancer	8.58e-06	0.000288	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTP1—kidney cancer	8.53e-06	0.000287	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—MAPK3—kidney cancer	8.12e-06	0.000273	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ABCB1—kidney cancer	8.07e-06	0.000271	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTM1—kidney cancer	7.84e-06	0.000263	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CRABP1—kidney cancer	7.83e-06	0.000263	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.77e-06	0.000261	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—MAPK1—kidney cancer	7.73e-06	0.00026	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTP1—kidney cancer	7.66e-06	0.000257	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP1A1—kidney cancer	7.43e-06	0.00025	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—KRAS—kidney cancer	7.3e-06	0.000245	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ITPR2—kidney cancer	7.28e-06	0.000245	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ABCB1—kidney cancer	7.25e-06	0.000244	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTM1—kidney cancer	7.04e-06	0.000236	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CA—kidney cancer	6.7e-06	0.000225	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP1A1—kidney cancer	6.67e-06	0.000224	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ACHE—kidney cancer	6.64e-06	0.000223	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTT1—kidney cancer	6.64e-06	0.000223	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TP53—kidney cancer	6.49e-06	0.000218	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—POMC—kidney cancer	6.43e-06	0.000216	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SCARB1—kidney cancer	6.29e-06	0.000211	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PTGS1—kidney cancer	6.22e-06	0.000209	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.1e-06	0.000205	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PSMD7—kidney cancer	6.1e-06	0.000205	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—BCHE—kidney cancer	5.79e-06	0.000194	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.72e-06	0.000192	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—POMC—kidney cancer	5.54e-06	0.000186	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.52e-06	0.000186	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.48e-06	0.000184	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PTGS2—kidney cancer	5.13e-06	0.000172	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—POMC—kidney cancer	4.97e-06	0.000167	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTP1—kidney cancer	4.6e-06	0.000155	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PTEN—kidney cancer	4.47e-06	0.00015	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PTGS2—kidney cancer	4.42e-06	0.000148	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ABCB1—kidney cancer	4.36e-06	0.000146	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTM1—kidney cancer	4.23e-06	0.000142	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.01e-06	0.000135	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PTGS2—kidney cancer	3.97e-06	0.000133	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PTEN—kidney cancer	3.85e-06	0.000129	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PTEN—kidney cancer	3.46e-06	0.000116	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CA—kidney cancer	3.16e-06	0.000106	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—POMC—kidney cancer	2.99e-06	0.0001	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CA—kidney cancer	2.72e-06	9.14e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.44e-06	8.2e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PTGS2—kidney cancer	2.38e-06	8.02e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PTEN—kidney cancer	2.08e-06	6.99e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.47e-06	4.93e-05	CbGpPWpGaD
